MRMD vs MTEX: stock comparison and AI forecast
Marimed Inc. (MRMD) and Mannatech Inc (MTEX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
MRMD Marimed Inc.
- Market Cap
- $26M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
MTEX Mannatech Inc
- Market Cap
- $16M
- P/E Ratio
- 6.6x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- MRMD is 1.7 times larger than MTEX by market capitalization ($26M against $16M).
- Both companies share the SEC industry classification Medicinal Chemicals & Botanical Products.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | MRMD | MTEX |
|---|---|---|
| Market Cap | $26M | $16M |
| P/E Ratio | – | 6.55x |
| P/B Ratio | 0.58x | – |
| EPS | $-0.05 | $1.23 |
| Book Value/Share | $0.11 | – |
| Revenue/Share | $0.41 | – |
| FCF/Share | $0.02 | – |
Profitability & Margins
| Metric | MRMD | MTEX |
|---|---|---|
| ROE | -33.5% | – |
| ROA | -7.7% | – |
| ROIC | -1.9% | 18.8% |
| Gross Margin | 35.6% | 74.0% |
| Operating Margin | -1.6% | 1.8% |
| Net Margin | -9.2% | – |
| EBT Margin | -6.3% | 3.1% |
| Tax Rate | -45.8% | 31.9% |
Financial Health
| Metric | MRMD | MTEX |
|---|---|---|
| Current Ratio | 0.92x | 1.15x |
| Quick Ratio | 0.34x | 0.58x |
| D/E Ratio | 3.26x | – |
| Financial Leverage | 4.37x | – |
| Interest Coverage | 0.2x | 4.1x |
| Working Capital | -$5M | $3M |
Cash Flow
| Metric | MRMD | MTEX |
|---|---|---|
| Operating Cash Flow | $9M | -$1M |
| Free Cash Flow | $8M | – |
| Capital Spending | -$1M | – |
| OCF Growth YoY | 368.3% | -153.7% |
| FCF/Sales | 4.9% | – |
| CapEx/Sales | 0.8% | – |
Operational Efficiency
| Metric | MRMD | MTEX |
|---|---|---|
| Asset Turnover | 0.83x | – |
| Receivables Turnover | 17.5x | – |
| Inventory Turnover | 2.9x | 2.7x |
| Fixed Assets Turnover | 1.9x | – |
| Days Sales Outstanding | 21 days | – |
| Days Inventory | 127 days | 135 days |
| Payables Period | 46 days | 52 days |
| Cash Conversion Cycle | 102 days | – |
Income Statement
| Metric | MRMD | MTEX |
|---|---|---|
| Total Revenue | $164M | – |
| Operating Income | -$3M | $2M |
| Net Income | -$15M | – |
| SG&A Expense | – | $43M |
| Cost of Goods Sold | $105M | $26M |
Dividend & Shareholder Information
| Metric | MRMD | MTEX |
|---|---|---|
| Shares Outstanding | 403M | 2M |
| EPS Growth | – | -6.8% |
MRMD vs MTEX: stock comparison and AI forecast
Which is bigger, MRMD or MTEX?
MRMD is 1.7 times larger than MTEX by market capitalization ($26M against $16M).
Which one does Intratio's AI model rank higher, MRMD or MTEX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.